Early alterations of B cells in patients with septic shock: another piece in the complex puzzle of the immune response in sepsis by Girardis, Massimo & Cossarizza, Andrea
 e immune system has evolved for several million years 
to ameliorate the defenses of our organism from any kind 
of pathogens, including those causing sepsis, a life-
threatening condition in which almost all components of 
the innate and adaptive immune system have to work 
together in a coordinated manner. However, in septic 
hosts, a deregulated response to infection may lead to a 
sustained systemic infl ammation that causes the failure 
to clear primary pathogens and alters immune responses. 
 e study by Monserrat and colleagues [1] in the pre-
vious issue of Critical Care adds one more piece in this 
complex puzzle by evaluating the early subset distri-
bution and activation of circulating B-lymphocytes in 
patients with septic shock. But what is the relevance of 
the B-cell compartment in this puzzle? To better under-
stand this issue, a brief and schematic description of the 
immune response is desirable.
Infl ammatory response to pathogens can be triggered 
by several mechanisms.  e fi rst is the activation of 
several Toll-like receptors present on cells of the innate 
immunity (for example, monocytes, granulocytes, den-
dritic cells, and natural killer cells) that recognize pathogen-
associated molecular patterns (PAMPs) present in or 
released by the invading microorganisms.  e activation 
of these cells results in the production of pro-
infl ammatory cytokines – that is, interleukin (IL)-1, IL-6, 
IL-10, and tumor necrosis factor-alpha (TNF-α)  – and 
vasoactive peptides, complement, and reactive oxygen 
species that together start a generalized infl ammation 
[2]. A second response mechanism involves the a ctivation 
of CD4+ T lymphocytes that bear particular amino-acid 
sequences in the variable region of the β-chain (V) of 
their T-cell receptor (TCR). Each T cell bearing a given 
Vβ TCR can bind bacterial (or even viral) products in a 
non-major histocompatibility complex-restricted manner 
(that is, outside from the region where the clonal-specifi c 
recognition of a unique antigen occurs); for this reason, 
such molecules, which activate a large percentage of 
T  cells that are in fact specifi c for other molecules, are 
defi ned as superantigens (SAgs) [3]. An SAg like the 
staphylococcal enterotoxin B is massively released during 
sepsis and can activate up to 30% of T cells, which pro-
duce several cytokines, including IL-17A, IL-2, inter-
feron-gamma, and TNF-α. However, activated cells have 
a high tendency to develop mitochondrial damage and 
undergo apoptosis, and this clearly results in a further 
impaired immune response [4]. Pro-infl ammatory cyto-
kines can also activate a high amount of B cells. A family 
of B-lymphocytes (known as B-1 cells, which are unable 
to further diff erentiate into mature B cells) located mainly 
in the peritoneal and pleural cavities can produce 
immuno globulin M (IgM) and IL-10 and modu late the 
systemic infl ammatory response. Studies in mice have 
identifi ed the presence of an eff ector B-cell population 
that protects against microbial sepsis [5].  ese cells, 
defi ned as innate response activators, depend on PAMP 
receptors and produce granulocyte-macrophage colony-
stimulating factor.  eir deletion impairs bacterial 
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clearance, elicits a cytokine storm, and can precipitate 
septic shock.
 e above brief description highlighted the role and the 
importance of the B-cell compartment in the initial 
immune response to infection; hence, the data provided 
by Monserrat and colleagues [1] are really helpful in 
providing more insight in this issue. In 52  septic shock 
patients who were admitted to the intensive care unit 
(ICU), the authors observed an early (that is, within 
24 hours) and sustained circulating B-cell reduction that 
was associated with a signifi cant redistribution of B-cell 
subsets compared with healthy subjects.  e CD19+CD23+ 
B cells (activated regulatory B cells) were lower in non-
survivors than in survivors for the 7 days of the follow-
up, whereas CD19+CD69+ (early activated B cells) and the 
expression of critical antigens on B cells (CD80, a T-cell 
co-stimulation molecule, and CD95, an apoptosis 
susceptibility marker) were higher in non-survivors. 
Moreover, lymphopenia and an increased expression of 
CD80 persisted in survivors for all 28 days of the study 
period.  e authors concluded that, in patients with 
septic shock, the circulating B-cell compartment is early 
and deeply altered in both quantitative and qualitative 
terms and that there is a close relationship between these 
alterations and patient outcome.
 e fi nal message from the article is sound and in 
accordance with previous studies on the other compo-
nents of the immune response (that is, dendritic cells, 
natural killer cells, and T-lymphocytes) that in patients 
with septic shock revealed a signifi cant decrease in the 
number and function of the immune cells with early signs 
of apoptosis and cell exhaustion in non-survivors [6-10]. 
However, the reasons for this diff erent pattern between 
survivors and non-survivors remained to be clarifi ed. A 
recent article by Gogos and colleagues [9] indicated that 
the alterations in natural killer cells and T-lymphocytes 
depend on the severity of sepsis and the site and type of 
infection.  e time length from infection to the onset of 
septic shock (and to its treatment) may also have an 
important role: the longer the time, the larger the 
expected activation and exhaustion of the infl ammatory 
and immune response [10,11]. Lastly, genetic factors 
could also be connected to the expression of diff erent 
immune patterns among patients with similar types of 
infection and sepsis severity [12]. Unfortunately, owing to 
the low number of patients studied and the diffi  culties to 
defi ne the time length from infection to ICU admission, 
the article by Monserrat and colleagues [1] cannot off er a 
proper analysis of these issues and leaves the question 
open.
Whatever the reasons for the diff erences observed in 
the immune system, the study by Monserrat and colleagues 
emphasizes once again that immunosuppression is 
common even in the early stages of sepsis and that 
patients with sepsis constitute a complex and hetero-
geneous population requiring specifi c monitoring and 
individualized therapeutic approaches. Immune-modula-
tory therapies tailored to the immune state of the patients 
will be the object of future clinical trials [13]. In the 
meantime, as in other pathologies with variable disorders 
of the immune system (for example, cancer and rheuma-
tologic diseases), monitoring the immune-infl ammatory 
state in septic shock patients admitted to the ICU could 
be useful for identifying the high-risk patients and the 
fl uctuating infl ammatory-immune response.
Abbreviations
ICU, intensive care unit; IL, interleukin; PAMP, pathogen-associated molecular 
pattern; SAg, superantigen; TCR, T-cell receptor; TNF-α, tumor necrosis factor-
alpha; V, variable region of the beta-chain.
Competing interests
The authors declare that they have no competing interests.
Author details
1Intensive Care Unit, University of Modena and Reggio Emilia, L.go del Pozzo 
71, 41125 Modena, Italy. 2Immunology, Department of Surgery, Medicine, 
Dentistry and Morphological Sciences, University of Modena and Reggio 
Emilia, via Campi 287, 41125 Modena, Italy.
Published: 10 July 2013
References
1.  Monserrat J, de Pablo R, Diaz-Martin D, Rodriguez-Zapata M, de la Hera A, 
Prieto A, Alvarez-Mon M: Early alterations of B cells in patients with septic 
shock. Crit Care 2013, 17:R105.
2.  Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG: 
The pathogenesis of sepsis. Annu Rev Pathol 2011, 6:19.
3.  Cossarizza A: T-cell repertoire and HIV infection: facts and perspectives. 
AIDS 1997, 11:1075-1088.
4.  Lugli E, Troiano L, Ferraresi R, Roat E, Prada N, Nasi M, Pinti M, Cooper EL, 
Cossarizza A: Characterization of cells with di erent mitochondrial 
membrane potential during apoptosis. Cytometry A 2005, 68:28.
5.  Rauch PJ, Chudnovskiy A, Robbins CS, Weber GF, Etzrodt M, Hilgendorf I, 
Tiglao E, Figueiredo JL, Iwamoto Y, Theurl I, Gorbatov R, Waring MT, Chicoine 
AT, Mouded M, Pittet MJ, Nahrendorf M, Weissleder R, Swirski FK: Innate 
response activator B cells protect against microbial sepsis. Science 2012, 
335:597.
6.  Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr., Hui JJ, Chang KC, 
Osborne DF, Freeman BD, Cobb JP, Buchman TG, Karl IE: Sepsis-induced 
apoptosis causes progressive profound depletion of B and 
CD4+ T lymphocytes in humans. J Immunol 2001, 166:6952.
7.  Monserrat J, de Pablo R, Reyes E, Díaz D, Barcenilla H, Zapata MR, De la Hera A, 
Prieto A, Alvarez-Mon M: Clinical relevance of the severe abnormalities of 
the T cell compartment in septic shock patients. Crit Care 2009, 13:R26.
8.  Boomer JS, Shuherk-Sha er J, Hotchkiss RS, Green JM: A prospective analysis 
of lymphocyte phenotype and function over the course of acute sepsis. 
Crit Care 2012, 16:R112.
9.  Gogos C, Kotsaki A, Pelekanou A, Giannikopoulos G, Vaki I, Maravitsa P, 
Adamis S, Alexiou Z, Andrianopoulos G, Antonopoulou A, Athanassia S, 
Baziaka F, Charalambous A, Christodoulou S, Dimopoulou I, Floros I, 
Giannitsioti E, Gkanas P, Ioakeimidou A, Kanellakopoulou K, Karabela N, 
Karagianni V, Katsarolis I, Kontopithari G, Kopterides P, Koutelidakis I, 
Koutoukas P, Kranidioti H, Lignos M, Louis K, et al.: Early alterations of the 
innate and adaptive immune statuses in sepsis according to the type of 
underlying infection. Crit Care 2010, 14:R96.
10. Venet F, Davin F, Guignant C, Larue A, Cazalis MA, Darbon R, Allombert C, 
Mougin B, Malcus C, Poitevin-Later F, Lepape A, Monneret G: Early 
assessment of leukocyte alterations at diagnosis of septic shock. Shock 
2010, 34:358.
11. Venet F, Filipe-Santos O, Lepape A, Malcus C, Poitevin-Later F, Grives A, 
Plantier N, Pasqual N, Monneret G: Decreased T-cell repertoire diversity in 
Girardis and Cossarizza Critical Care 2013, 17:162 
http://ccforum.com/content/17/4/162
Page 2 of 3
sepsis: a preliminary study. Crit Care Med 2013, 41:111.
12. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, 
Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, 
Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke 
MG, López MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, 
Calvano SE, McDonald-Smith GP, et al.: A genomic storm in critically injured 
humans. J Exp Med 2011, 208:2581.
13. Hotchkiss RS, Monneret G, Payen D: Immunosuppression in sepsis: a novel 
understanding of the disorder and a new therapeutic approach. Lancet 
Infect Dis 2013, 13:260.
doi:10.1186/cc12778
Cite this article as: Girardis M, Cossarizza A: Early alterations of B cells in 
patients with septic shock: another piece in the complex puzzle of the 
immune response in sepsis. Critical Care 2013, 17:162.
Girardis and Cossarizza Critical Care 2013, 17:162 
http://ccforum.com/content/17/4/162
Page 3 of 3
